A Safety & Efficacy Study of PVX108 in Children & Adolescents With Peanut

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03663933` - Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation	Phase 2
Completed	`NCT03563066` - Effect of Benralizumab in Atopic Dermatitis	Phase 2
Recruiting	`NCT04339777` - Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity	Phase 2
Not yet recruiting	`NCT05969821` - Clonal Hematopoiesis of Immunological Significance
Completed	`NCT02916888` - A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists	N/A
Completed	`NCT02527187` - Determination of the Sensitivity and Specificity of Prick Test Betula Verrucosa	Phase 2
Completed	`NCT01441076` - Anakinra for Behcet s Disease	Phase 1/Phase 2
Completed	`NCT01472263` - Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) Diseases	Phase 3
Completed	`NCT03720470` - Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy	Phase 3
Suspended	`NCT04642066` - Cold Water Immersion and Atherosclerosis, Inflammation, Fat Accumulation and Lipid Profile Parameters	N/A
Completed	`NCT02294552` - Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT	Phase 2
Completed	`NCT01727973` - Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy	Phase 1/Phase 2
Completed	`NCT04103099` - Impact of HLNatural Immune Supplement on Colds	N/A
Recruiting	`NCT03344094` - Mechanism of Action of Ocrelizumab in Multiple Sclerosis	N/A
Active, not recruiting	`NCT05445284` - Group Education Trial to Improve Transition for Parents of Adolescents With T1D	N/A
Recruiting	`NCT06104111` - Epigenetic Memory of Vitamin D Supplementation	Phase 1
Not yet recruiting	`NCT05616117` - Next-generation Effects of Vitamin D Supplementation in Pregnancy
Completed	`NCT01490177` - Single Center Food Allergy Oral Immunotherapy Study	Phase 1
Completed	`NCT01510626` - Omalizumab With Oral Food Immunotherapy With Food Allergies Open Label Safety Study in a Single Center	Phase 1
Completed	`NCT03922087` - No-worry Baby Project

NCT number	NCT05621317
Study type	Interventional
Source	Aravax Pty Ltd
Contact
Status	Recruiting
Phase	Phase 2
Start date	February 9, 2023
Completion date	July 2025

A Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut Allergy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms